On the contrary, the expression levels of VEGFB and TNFRSF14 were negatively correlated with HS6ST2 in breast invasive carcinoma, cervical squamous cell carcinoma and endocervical adenocarcinoma, lung squamous cell carcinoma, brain lower grade glioma, ovarian serous cystadenocarcinoma, skin cutaneous melanoma, sarcoma, thymoma, and uterine corpus endometrial carcinoma (Fig. 10F,G). Here, VEGFB is linked to thymoma.